Citius Pharmaceuticals and Traws Pharma Release Q2 Earnings

Citius Pharmaceuticals reported a GAAP EPS of -$0.34, missing estimates, with revenue of $1.5M also falling short. In contrast, Traws Pharma announced a GAAP EPS of -$0.16, surpassing expectations.